U.S. Physical Therapy, Inc. (USPH) Receives $111.40 Consensus PT from Brokerages

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have earned a consensus rating of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $111.40.

Several equities research analysts recently issued reports on the company. ValuEngine downgraded U.S. Physical Therapy from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, March 6th. Barrington Research reaffirmed a “hold” rating on shares of U.S. Physical Therapy in a research report on Friday, May 3rd. William Blair initiated coverage on U.S. Physical Therapy in a research report on Thursday, March 7th. They issued an “outperform” rating and a $106.61 target price on the stock. Zacks Investment Research lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Saturday, February 9th. Finally, TheStreet upgraded U.S. Physical Therapy from a “c+” rating to a “b” rating in a report on Friday, March 8th.

In other U.S. Physical Therapy news, COO Glenn Mcdowell sold 6,204 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $107.23, for a total transaction of $665,254.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harry S. Chapman bought 950 shares of U.S. Physical Therapy stock in a transaction dated Monday, March 18th. The stock was purchased at an average price of $105.33 per share, with a total value of $100,063.50. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 18,629 shares of company stock valued at $2,078,095. Company insiders own 2.50% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. 361 Capital LLC lifted its position in U.S. Physical Therapy by 9.2% in the 1st quarter. 361 Capital LLC now owns 27,695 shares of the company’s stock valued at $2,909,000 after acquiring an additional 2,344 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in U.S. Physical Therapy by 1.8% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 4,913 shares of the company’s stock valued at $516,000 after acquiring an additional 89 shares in the last quarter. Mason Street Advisors LLC lifted its position in U.S. Physical Therapy by 3.4% in the 1st quarter. Mason Street Advisors LLC now owns 4,074 shares of the company’s stock valued at $428,000 after acquiring an additional 135 shares in the last quarter. Cadence Capital Management LLC lifted its position in U.S. Physical Therapy by 104.1% in the 1st quarter. Cadence Capital Management LLC now owns 27,176 shares of the company’s stock valued at $2,854,000 after acquiring an additional 13,859 shares in the last quarter. Finally, Everence Capital Management Inc. bought a new position in U.S. Physical Therapy in the 1st quarter valued at about $215,000. Institutional investors own 99.58% of the company’s stock.

Shares of NYSE USPH traded up $0.08 during mid-day trading on Friday, hitting $116.90. 1,498 shares of the company traded hands, compared to its average volume of 88,967. U.S. Physical Therapy has a 1 year low of $88.88 and a 1 year high of $129.65. The company has a market cap of $1.48 billion, a price-to-earnings ratio of 43.99, a P/E/G ratio of 3.55 and a beta of 1.15. The company has a quick ratio of 1.89, a current ratio of 1.18 and a debt-to-equity ratio of 0.39.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, May 2nd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.62 by $0.04. The business had revenue of $116.23 million during the quarter, compared to the consensus estimate of $114.12 million. U.S. Physical Therapy had a return on equity of 19.09% and a net margin of 5.34%. U.S. Physical Therapy’s quarterly revenue was up 7.3% on a year-over-year basis. As a group, sell-side analysts expect that U.S. Physical Therapy will post 2.9 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Friday, May 17th will be issued a dividend of $0.27 per share. The ex-dividend date is Thursday, May 16th. This represents a $1.08 dividend on an annualized basis and a yield of 0.92%. U.S. Physical Therapy’s payout ratio is currently 40.75%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Story: Futures Contract

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.